InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.16
(
0.47%
)
US TECH 100
18,024.00
(
0.56%
)
Dow Jones
39,497.54
(
0.13%
)
Brent Oil
79.49
(
0.00%
)
Bitcoin
61,038.12
(
0.15%
)
Post# of 7234
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

The GidDy uP Kid

Send PM Follow Ignore
Followers 125
Posts 14408
Boards Moderated 4
Alias Born 04/15/2008

The GidDy uP Kid

Re: dylyo post# 1422

Friday, 03/27/2009 11:13:22 AM

Friday, March 27, 2009 11:13:22 AM

Post# of 7234
"This communication from the FDA is a significant milestone for the
Company and for patients with relapsed aggressive NHL as this could be the
first drug approved for this unmet medical need," noted James A. Bianco, M.D.
Chief Executive Officer of CTI. "With the potential for three drug approvals
in 2009 we are on track to meet our objective of cash flow break even in the
fourth quarter of this year."

http://www.reuters.com/article/pressRelease/idUS56559+27-Jan-2009+PRN20090127

"Winner, Winner, Chicken Dinner"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up